cycloartane has been researched along with Innate Inflammatory Response in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Akgün, İH; Bedir, E; Debeleç-Bütüner, B; Korkmaz, KS; Öztürk, MB; Tağ, Ö; Yetik-Anacak, G | 1 |
| Achounna, AS; Greffrath, W; Ngnokam, D; Nguelefack, TB; Piegang, BN; Tigoufack, IB; Treede, RD; Watcho, P | 1 |
2 other study(ies) available for cycloartane and Innate Inflammatory Response
| Article | Year |
|---|---|
Cycloartane-type sapogenol derivatives inhibit NFκB activation as chemopreventive strategy for inflammation-induced prostate carcinogenesis.
Topics: Apoptosis; Carcinogenesis; Cell Line, Tumor; Cell Proliferation; Chemoprevention; Dinoprostone; Humans; Inflammation; Male; NF-kappa B; Prostatic Neoplasms; Sapogenins; Signal Transduction; Transcription, Genetic; Triterpenes | 2018 |
Cycloartanes from Oxyanthus pallidus and derivatives with analgesic activities.
Topics: Analgesics; Animals; Antioxidants; Female; Formaldehyde; Hyperalgesia; Inflammation; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; Pain; Phytotherapy; Plant Extracts; Rats, Wistar; Rubiaceae; Superoxide Dismutase; Triterpenes | 2016 |